None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients scheduled for hip surgery, ASA I~III
Exclusion criteria
Exclusion criteria: Patients with planned regional anesthesia such as spinal/epithelial anesthesia, patients who underwent nerve block for pain control, with BMI 35 kg/m2 or more, with baseline MBP less than 60 mmHg, with baseline heart rate less than 45 bpm/120 bpm , patients on chronic opioid medications, arrhythmias, patients on implanted pacemaker, patients taking alpha 2 adrenergic agonists, beta 1 adrenergic antagonists, antiarrhythmic agents, patients with central/autonomous nervous system disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraoperative remifentanil total dose | — |
Secondary
| Measure | Time frame |
|---|---|
| the adverse event due to opioid use | — |
Countries
Korea, Republic of
Contacts
Inje University Ilsan Paik Hospital